Janus Henderson Group’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-644
Closed -$355K 2605
2022
Q1
$355K Hold
644
﹤0.01% 2116
2021
Q4
$426K Buy
644
+324
+101% +$248K ﹤0.01% 1992
2021
Q3
$269K Buy
+320
New +$325K ﹤0.01% 1948

Other funds holding CDLX

Janus Henderson Group's CDLX Position: Q2 2022 in Review

Janus Henderson Group sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 644 shares — an estimated $355K sold.

Janus Henderson Group first reported a position in CDLX in Q3 2021 and held it in 3 quarters. The position peaked at $426K in Q4 2021. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.

  • Janus Henderson Group reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
  • Janus Henderson Group sold 644 Cardlytics shares in Q2 2022, an estimated $355K.
  • Janus Henderson Group first reported a position in Cardlytics in Q3 2021 and held it in 3 quarters.
  • Janus Henderson Group's Cardlytics position peaked at $426K in Q4 2021.
  • 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.

Based on Janus Henderson Group's 13F filing for Q2 2022, filed 15 Aug 2022.